Patents by Inventor Franziska Sophie BOOTZ

Franziska Sophie BOOTZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL22 immunoconjugates
    Patent number: 10858411
    Abstract: The application relates to a conjugate comprising interleukin-22 (IL22) and an antibody molecule. The antibody molecule preferably binds an antigen associated with angiogenesis, such as the ED-A isoform of fibronectin. In particular, the application relates to the therapeutic use of such conjugates in the treatment of a disease/disorder, such as autoimmune diseases, including inflammatory bowel disease (IBD).
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: December 8, 2020
    Assignee: Philogen S.P.A.
    Inventors: Franziska Sophie Bootz, Dario Neri
  • IL22 IMMUNOCONJUGATES
    Publication number: 20190169250
    Abstract: The application relates to a conjugate comprising interleukin-22 (IL22) and an antibody molecule. The antibody molecule preferably binds an antigen associated with angiogenesis, such as the ED-A isoform of fibronectin. In particular, the application relates to the therapeutic use of such conjugates in the treatment of a disease/disorder, such as autoimmune diseases, including inflammatory bowel disease (IBD).
    Type: Application
    Filed: February 20, 2019
    Publication date: June 6, 2019
    Applicant: Philogen S.P.A.
    Inventors: Franziska Sophie Bootz, Dario Neri
  • IL22 immunoconjugates
    Patent number: 10246502
    Abstract: The application relates to a conjugate comprising interleukin-22 (IL22) and an antibody molecule. The antibody molecule preferably binds an antigen associated with angiogenesis, such as the ED-A isoform of fibronectin. In particular, the application relates to the therapeutic use of such conjugates in the treatment of a disease/disorder, such as autoimmune diseases, including inflammatory bowel disease (IBD).
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: April 2, 2019
    Assignee: Philogen S.P.A.
    Inventors: Franziska Sophie Bootz, Dario Neri
  • IL22 IMMUNOCONJUGATES
    Publication number: 20170305989
    Abstract: The application relates to a conjugate comprising interleukin-22 (IL22) and an antibody molecule. The antibody molecule preferably binds an antigen associated with angiogenesis, such as the ED-A isoform of fibronectin. In particular, the application relates to the therapeutic use of such conjugates in the treatment of a disease/disorder, such as autoimmune diseases, including inflammatory bowel disease (IBD).
    Type: Application
    Filed: May 30, 2017
    Publication date: October 26, 2017
    Inventors: Franziska Sophie BOOTZ, Dario NERI